NanoSynex provides a rapid phenotypic antimicrobial susceptibility testing platform that delivers same‑day results using a disposable microfluidic test card, dedicated incubation hardware, and analysis software. The system integrates with existing laboratory information systems, enabling hospitals and diagnostic labs to obtain accurate susceptibility profiles within hours, supporting timely, targeted antibiotic therapy and reducing reliance on broad‑spectrum drugs.
Funding
$83.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current antimicrobial susceptibility testing (AST) in clinical laboratories often requires multiple days to yield results, delaying targeted antibiotic therapy and contributing to the overuse of broad-spectrum antibiotics, which accelerates resistance.
Solution
NanoSynex offers a rapid phenotypic AST platform that delivers same‑day susceptibility results. The system combines a disposable microfluidic test card, dedicated hardware for controlled bacterial growth, and analysis software that interprets the data. By optimizing bacterial proliferation in a compact cartridge, the platform produces reliable susceptibility profiles within hours instead of days. Results are delivered digitally to laboratory information systems, enabling clinicians to prescribe personalized antibiotics promptly and reducing unnecessary broad‑spectrum use. The solution is designed for integration into existing microbiology workflows, improving testing throughput while lowering overall healthcare costs.
Target Audience
Primary customers are clinical microbiology laboratories in hospitals and diagnostic centers that need rapid AST results to guide antibiotic prescribing.
Features
- Disposable microfluidic test card that standardizes sample handling and accelerates bacterial growth for phenotypic assessment
- Dedicated hardware unit that controls incubation conditions and captures optical/fluorescent readouts in real time
- Proprietary analysis software that translates raw signals into quantitative susceptibility results and generates clinician‑ready reports
- Compatibility with standard laboratory information systems for seamless data transfer and record keeping
- Same‑day turnaround time (hours) compared to conventional multi‑day AST methods
- Scalable design suitable for high‑volume clinical microbiology labs